Home Newsletter Honored Guests Blog About Us Work With Us Sponsor & Advertise Be a Guest The Production Suite Get the Briefing
Skip to main content

Open Door Salon

Mike Walker

Mike Walker

Health & Life Sciences Digital-Strategy Leader | Former Microsoft Executive Director & Gartner Analyst

Mike Walker is a digital-strategy leader in health and life sciences who advises pharmaceutical companies and biotechs on supply-chain security, cybersecurity, and digital transformation. He served as executive director of global health-and-life-sciences digital strategy at Microsoft, where he led the company’s point of view on how pharma, med-tech, and biopharma organizations modernize using digital ecosystems, digital twins, AI, and related technologies, and he was previously an analyst at Gartner.

Walker appeared on Open Door Salon alongside Clinton West, president of the supply chain security practice at Aardwolf Global Solutions and a former CIA supply-chain-risk leader, for a conversation on defending the pharmaceutical supply chain against cyber and geopolitical threats.

Walker’s lens was the deep technological dependency beneath the industry. The health-and-life-sciences supply chain, he argued, ultimately rests on the energy supply chain, with about a fifth of the world’s oil moving through the Strait of Hormuz, and on the semiconductor supply chain that runs from chip manufacturing through the data centers powering modern med-tech.

On cybersecurity, Walker made the case for proactive defense over reaction. As artificial intelligence grows more capable, he argued, attacks will scale through automation, and parts of the world operate without the AI restrictions that bind the US and Europe. Architecting supply chains and defenses to anticipate those threats, rather than respond to them after the fact, is the work he sees ahead.

Frequently Asked Questions About Mike Walker

What is Mike Walker an expert in?

Mike Walker is an expert in digital strategy for health and life sciences, advising pharmaceutical companies and biotechs on supply-chain security, cybersecurity, and digital transformation. His work spans digital ecosystems, digital twins, and AI in pharma and med-tech.

Who is Mike Walker?

Mike Walker is a digital-strategy leader in health and life sciences. He served as executive director of global health-and-life-sciences digital strategy at Microsoft, where he led the company's point of view on how pharma, med-tech, and biopharma organizations modernize using digital ecosystems, digital twins, and AI, and he was previously an analyst at Gartner. He appeared on Open Door Salon, the life sciences podcast hosted by Lori Ellis.

How does Mike Walker think about pharma supply-chain and cyber risk?

Mike Walker's lens is the deep technological dependency beneath the industry: the health-and-life-sciences supply chain ultimately rests on the energy supply chain, with about a fifth of the world's oil moving through the Strait of Hormuz, and on the semiconductor supply chain that runs from chip manufacturing through the data centers powering modern med-tech. On cybersecurity he argues for proactive defense over reaction, because as AI grows more capable, attacks will scale through automation.

On Open Door Salon

“Cyberattacks and Closed Straits: Defending Pharma on Two Fronts”
Clinton West & Mike Walker · May 13, 2026

Episode page & show notes on Open Door Salon

“it’s really dependent on another key supply chain that fuels all supply chains, which is the energy supply chain”Mike Walker, on Open Door Salon (on energy as the supply chain beneath all supply chains)
“you have adversaries that are looking at your supply chain with precision on where are the breakpoints. Not necessarily supply and demand.”Mike Walker, on Open Door Salon (on adversaries targeting supply-chain break points)
“When we say resilience, really traditionally what we thought of it as is reactive framework...if you’re truly resilient, you’ll have already made those hard decisions around things like optionality”Mike Walker, on Open Door Salon (on proactive resilience versus reacting to disruption)

In this episode

  • Energy as the supply chain beneath all supply chains
  • From chip manufacturing to the data center
  • Proactive defense vs. reacting to attacks
  • AI-scaled attacks and uneven global restrictions
  • Modernizing brittle, legacy supply chains
  • The digital-transformation lens on pharma security
  • Advising pharma and biotech on cyber resilience

Topics

Digital StrategyHealth & Life SciencesSupply Chain SecurityCybersecurityDigital TransformationAI in PharmaDigital TwinsPharma TechnologyMed-TechData Centers

Watch on Open Door Salon

Cyberattacks and Closed Straits: Defending Pharma on Two Fronts | Clinton West & Mike Walker

Open Door Salon brings life-sciences leaders into candid conversation. Every Monday, the week's takeaways land in your inbox.

Subscribe on Substack →
The Briefing

Need the life-sciences signal but short on time?

Get the free quarterly briefing: every guest from the quarter, in one sitting. What decides whether a therapy reaches a patient, gets funded, and can be trusted.